BioArctic AB (publ) (BRCTF)
OTCMKTS · Delayed Price · Currency is USD
29.47
-0.29 (-0.99%)
Sep 15, 2025, 2:24 PM EDT
BioArctic AB Market Cap
BioArctic AB has a market cap or net worth of $2.57 billion as of September 15, 2025. Its market cap has increased by 86.38% in one year.
Market Cap
2.57B
Enterprise Value
2.36B
Revenue
195.55M
Ranking
n/a
PE Ratio
22.86
Stock Price
$29.47
Market Cap Chart
Since October 12, 2017, BioArctic AB's market cap has increased from 315.33M to 2.57B, an increase of 713.44%. That is a compound annual growth rate of 30.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 2.57B | 60.71% |
| Dec 30, 2024 | 1.60B | -31.92% |
| Dec 29, 2023 | 2.35B | 1.97% |
| Dec 30, 2022 | 2.30B | 98.17% |
| Dec 30, 2021 | 1.16B | 13.19% |
| Dec 30, 2020 | 1.03B | 14.35% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 750.21M |
| Tian'an Technology Group | 723.74M |
| Glass House Brands | 566.73M |
| Northwest Biotherapeutics | 390.10M |
| CytoDyn | 358.38M |
| American Oncology Network | 353.52M |